You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
News on diagnostic systems for drugs of abuse and toxicology.
Prescient offers a test that is designed to determine an individual's risk of opioid addiction by analyzing 16 genes in the brain's reward pathway.
The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward.
Researchers associated with the International Cannabis Consortium and 23andMe found a causal relationship between schizophrenia and cannabis use.
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.